Smith & Wesson (NASDAQ:SWBI) Delivers Impressive Q4 CY2025, Stock Jumps 11.8%

American firearms manufacturer Smith & Wesson (NASDAQ:SWBI) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 17.1% year on year to $135.7 million. Its non-GAAP profit of $0.08 per share was 60% above analysts’ consensus estimates.

Is now the time to buy Smith & Wesson? Find out by accessing our full research report, it’s free.

Company Overview

With a history dating back to 1852, Smith & Wesson (NASDAQ:SWBI) is a firearms manufacturer known for its handguns and rifles.

Revenue Growth

A company’s long-term performance is an indicator of its overall quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Smith & Wesson struggled to consistently generate demand over the last five years as its sales dropped at a 12.2% annual rate. This wasn’t a great result and suggests it’s a low quality business.

Long-term growth is the most important, but within consumer discretionary, product cycles are short and revenue can be hit-driven due to rapidly changing trends and consumer preferences. Smith & Wesson’s annualized revenue declines of 3.4% over the last two years suggest its demand continued shrinking.

This quarter, Smith & Wesson reported year-on-year revenue growth of 17.1%, and its $135.7 million of revenue exceeded Wall Street’s estimates by 8.1%.

Looking ahead, sell-side analysts expect revenue to decline by 1.5% over the next 12 months. While this projection is better than its two-year trend, it’s tough to feel optimistic about a company facing demand difficulties.

ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.

AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.

Operating Margin

Operating margin is a key measure of profitability. Think of it as net income - the bottom line - excluding the impact of taxes and interest on debt, which are less connected to business fundamentals.

Smith & Wesson’s operating margin has shrunk over the last 12 months and averaged 6% over the last two years. The company’s profitability was mediocre for a consumer discretionary business and shows it couldn’t pass its higher operating expenses onto its customers.

In Q4, Smith & Wesson generated an operating margin profit margin of 4.9%, up 3.1 percentage points year on year. This increase was a welcome development and shows it was more efficient.

Earnings Per Share

Revenue trends explain a company’s historical growth, but the long-term change in earnings per share (EPS) points to the profitability of that growth – for example, a company could inflate its sales through excessive spending on advertising and promotions.

Sadly for Smith & Wesson, its EPS declined by 41.8% annually over the last five years, more than its revenue. This tells us the company struggled because its fixed cost base made it difficult to adjust to shrinking demand.

In Q4, Smith & Wesson reported adjusted EPS of $0.08, up from $0.02 in the same quarter last year. This print easily cleared analysts’ estimates, and shareholders should be content with the results. Over the next 12 months, Wall Street expects Smith & Wesson’s full-year EPS of $0.24 to grow 16.7%.

Key Takeaways from Smith & Wesson’s Q4 Results

It was good to see Smith & Wesson beat analysts’ EPS expectations this quarter. We were also excited its EBITDA outperformed Wall Street’s estimates by a wide margin. Zooming out, we think this quarter featured some important positives. The stock traded up 11.8% to $13.19 immediately following the results.

Smith & Wesson had an encouraging quarter, but one earnings result doesn’t necessarily make the stock a buy. Let’s see if this is a good investment. The latest quarter does matter, but not nearly as much as longer-term fundamentals and valuation, when deciding if the stock is a buy. We cover that in our actionable full research report which you can read here (it’s free).